ARCHIVES

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

This article is from The Cancer Letter archive.

Vol. 19 No. 34 | September 3, 1993

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve $160-Million Network For Biomarker Discovery, Validation

March 13, 2009

‘Meta-analysis’ Of Early Breast Cancer Trials finds Adjuvant Therapy Significantly Prolongs Life

January 10, 1992

Cancer Policy: Board Plans Paper On Tobacco Control

June 13, 1997

Survivorship Studies Unfocused As Total Research Increases

November 25, 2011

DCPC Board Approves Concepts For New Master Agreement, Recompetitions

October 9, 1987

Nelvis Castro To Serve As Acting OCC Chief; HHS Selects ANA President Malone.

January 7, 2000